Related Experiment Video
Updated: Jun 19, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Making the case for molecular staging of malignant pleural mesothelioma
1Division of Thoracic Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. Rbueno@partners.org
Seminars in Thoracic and Cardiovascular Surgery
|October 14, 2009
Abstract:
Malignant pleural mesothelioma is an aggressive malignancy for which surgical treatment is an option for a subset of patients. A gene ratio test based on the relative expression levels of four genes has been validated in clinical trials to predict which patients will benefit from surgical therapy. A description of the test properties and the independent predictors for outcome are provided.
